Esophageal cancer Trials in Rochester, United States
Conditions / Esophageal cancer / Rochester, United States
Esophageal cancer has been the subject of sustained clinical investigation across multiple research sites.
42 total trials for this combination
Showing top 10 of 42 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05891171 | Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT07431281 | Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 | RECRUITING | PHASE3 |
| NCT02960594 | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse | COMPLETED | PHASE1 |
| NCT00654160 | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer | COMPLETED | PHASE1 |
| NCT00052910 | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | COMPLETED | PHASE3 |
| NCT02349412 | Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers | COMPLETED | PHASE3 |
| NCT05366881 | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease | RECRUITING | — |
| NCT05500508 | Oral AMXT 1501 Dicaprate in Combination With IV DFMO | TERMINATED | PHASE1/PHASE2 |
| NCT04825834 | DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) | COMPLETED | — |
| NCT04772989 | A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies | COMPLETED | PHASE1 |